This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Crescendo Biologics Limited, Medimmune Limited. Active years: 2015-2024.
Company Filing History:
Years Active: 2015-2024
Title: The Innovative Contributions of Karen Bannister
Introduction
Karen Bannister is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of medical treatments, particularly through her innovative compositions aimed at addressing various disorders. With a total of 4 patents to her name, Bannister's work has the potential to impact the treatment of skin diseases and asthma.
Latest Patents
Among her latest patents, Bannister has developed compositions for the treatment of disorders. These inventions relate to stable and non-aggregating compositions that comprise an IL-17A binding molecule, specifically a single domain antibody. Such compositions are particularly useful for topical administration in the treatment of diseases, including skin diseases and asthma.
Career Highlights
Throughout her career, Bannister has worked with notable companies in the biotechnology sector, including Medimmune Limited and Crescendo Biologics Limited. Her experience in these organizations has allowed her to refine her expertise and contribute to groundbreaking research and development in her field.
Collaborations
Bannister has collaborated with several talented individuals, including Claire Louise Hope and Brendan Cormick Fish. These partnerships have further enhanced her innovative capabilities and have led to the development of impactful medical solutions.
Conclusion
Karen Bannister's contributions to the field of medical treatments through her innovative patents demonstrate her commitment to improving health outcomes. Her work continues to pave the way for advancements in the treatment of various disorders.